• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童呼吸道合胞病毒与新型冠状病毒2型感染的比较:住院病例对比

[RSV versus SARS-CoV-2 in children : Comparison of hospitalised cases].

作者信息

Brey Alexandra Victoria, Pengg Florian, Frischer Thomas, Zacharasiewicz Angela

机构信息

Faculty for Medicine, Sigmund Freud Private University, Freudplatz 3, 1020, Vienna, Austria.

Department of Pediatrics and Adolescent Medicine, Klinik Ottakring, Vienna, Austria, 1160.

出版信息

Wien Med Wochenschr. 2025 Sep 1. doi: 10.1007/s10354-025-01094-8.

DOI:10.1007/s10354-025-01094-8
PMID:40889028
Abstract

SARS-CoV‑2 and RSV are common viral pathogens causing acute respiratory infections. While RSV often leads to severe cases in children under two years, severe Covid-19 cases in children are rare. This study analysed 264 hospitalised children (0-12 years) with SARS-CoV‑2 or RSV infections between September 2021 and March 2022. RSV infections were more severe than SARS-CoV‑2 infections: 55% of RSV patients required oxygen therapy compared to 9.5% of SARS-CoV-2 cases (p < 0.001). The duration of oxygen therapy was 2 ± 2.6 days for RSV and 0.3 ± 1.07 days for SARS-CoV‑2. RSV patients required significantly longer O therapy (p < 0.001) and had longer hospital stays (p < 0.001) than SARS-CoV‑2 Omicron cases. Compared to Delta, only the O therapy duration was significantly longer in RSV cases (p < 0.001). Delta patients had longer hospital stays than Omicron patients (p < 0.001).

摘要

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)和呼吸道合胞病毒(RSV)是引起急性呼吸道感染的常见病毒病原体。虽然呼吸道合胞病毒常导致两岁以下儿童出现重症病例,但儿童感染新冠病毒的重症病例却很罕见。本研究分析了2021年9月至2022年3月期间264例因感染SARS-CoV-2或RSV而住院的儿童(0至12岁)。呼吸道合胞病毒感染比SARS-CoV-2感染更为严重:55%的呼吸道合胞病毒感染患者需要吸氧治疗,而感染SARS-CoV-2的患者这一比例为9.5%(p<0.001)。呼吸道合胞病毒感染患者吸氧治疗的持续时间为2±2.6天,而感染SARS-CoV-2的患者为0.3±1.07天。与感染SARS-CoV-2奥密克戎毒株的患者相比,呼吸道合胞病毒感染患者需要的吸氧治疗时间显著更长(p<0.001),住院时间也更长(p<0.001)。与感染德尔塔毒株的患者相比,只有呼吸道合胞病毒感染患者的吸氧治疗持续时间显著更长(p<0.001)。感染德尔塔毒株的患者住院时间比感染奥密克戎毒株的患者更长(p<0.001)。

相似文献

1
[RSV versus SARS-CoV-2 in children : Comparison of hospitalised cases].儿童呼吸道合胞病毒与新型冠状病毒2型感染的比较:住院病例对比
Wien Med Wochenschr. 2025 Sep 1. doi: 10.1007/s10354-025-01094-8.
2
Outcomes and Management of the SARS-CoV2 Omicron Variant in Recipients of Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy.造血细胞移植和嵌合抗原受体 T 细胞治疗患者中 SARS-CoV2 奥密克戎变异株的结局和管理。
Transplant Cell Ther. 2024 Jan;30(1):116.e1-116.e12. doi: 10.1016/j.jtct.2023.09.027. Epub 2023 Oct 6.
3
Epidemiology and surveillance of influenza, RSV and SARS-CoV-2 in children admitted with severe acute respiratory infection in West bengal, India from 2022 to 2023.2022年至2023年印度西孟加拉邦因严重急性呼吸道感染入院儿童中流感、呼吸道合胞病毒和新型冠状病毒2的流行病学及监测情况
BMC Infect Dis. 2025 Aug 20;25(1):1047. doi: 10.1186/s12879-025-11421-4.
4
Impact of Respiratory Syncytial Virus and Severe Acute Respiratory Syndrome Coronavirus 2 Coinfection on Clinical Severity and Outcomes Among Children Hospitalized With Lower Respiratory Tract Infections in Soweto, South Africa.呼吸道合胞病毒与严重急性呼吸综合征冠状病毒2合并感染对南非索韦托下呼吸道感染住院儿童临床严重程度及预后的影响
Pediatr Infect Dis J. 2025 Feb 1;44(2):107-111. doi: 10.1097/INF.0000000000004560. Epub 2024 Oct 2.
5
Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection.免疫球蛋白治疗住院婴儿和幼儿呼吸道合胞病毒感染。
Cochrane Database Syst Rev. 2023 Oct 23;10(10):CD009417. doi: 10.1002/14651858.CD009417.pub3.
6
Risk of Incidence and Lethality by Etiology of Severe Acute Respiratory Syndrome in Hospitalized Children Under 1 Year of Age in Brazil in 2024: A Cross-Sectional Study.2024年巴西1岁以下住院儿童严重急性呼吸综合征病因的发病率和致死率风险:一项横断面研究
Trop Med Infect Dis. 2025 Jun 14;10(6):168. doi: 10.3390/tropicalmed10060168.
7
Efficacy and safety of COVID-19 vaccines.新型冠状病毒疫苗的有效性和安全性。
Cochrane Database Syst Rev. 2022 Dec 7;12(12):CD015477. doi: 10.1002/14651858.CD015477.
8
Adapting COVID-19 research infrastructure to capture influenza and respiratory syncytial virus alongside SARS-CoV-2 in UK healthcare workers winter 2022/23 and beyond: protocol for a pragmatic sub-study.调整新冠病毒研究基础设施,以便在2022/23年冬季及以后在英国医护人员中同时收集流感病毒、呼吸道合胞病毒以及严重急性呼吸综合征冠状病毒2:一项务实子研究的方案
NIHR Open Res. 2024 Nov 5;4:1. doi: 10.3310/nihropenres.13517.2. eCollection 2024.
9
Evaluation of common respiratory viruses other than SARS-CoV-2 in hospitalized children during the COVID-19 pandemic.2019冠状病毒病大流行期间住院儿童中除严重急性呼吸综合征冠状病毒2之外的常见呼吸道病毒评估
BMC Infect Dis. 2025 Jul 11;25(1):910. doi: 10.1186/s12879-025-11293-8.
10
Risk Factors for Severe Disease Among Children Hospitalized With Respiratory Syncytial Virus.呼吸道合胞病毒住院儿童重症疾病的危险因素
JAMA Netw Open. 2025 Apr 1;8(4):e254666. doi: 10.1001/jamanetworkopen.2025.4666.

本文引用的文献

1
Inpatient burden of respiratory syncytial virus in children ≤2 years of age in Germany: A retrospective analysis of nationwide hospitalization data, 2019-2022.德国≤2 岁儿童呼吸道合胞病毒住院负担:2019-2022 年全国住院数据的回顾性分析。
Influenza Other Respir Viruses. 2023 Nov;17(11):e13211. doi: 10.1111/irv.13211.
2
Evaluation of post-COVID symptoms of the SARS-CoV-2 Delta and Omicron variants in children: a prospective study.儿童中SARS-CoV-2 Delta和Omicron变体的新冠后症状评估:一项前瞻性研究。
Eur J Pediatr. 2023 Oct;182(10):4565-4571. doi: 10.1007/s00431-023-05134-6. Epub 2023 Aug 1.
3
Prevalence and associating factors of long COVID in pediatric patients during the Delta and the Omicron variants.
德尔塔和奥密克戎变异株流行期间儿科患者长期新冠的患病率及相关因素
Front Pediatr. 2023 May 24;11:1127582. doi: 10.3389/fped.2023.1127582. eCollection 2023.
4
Long COVID: major findings, mechanisms and recommendations.长新冠:主要发现、机制和建议。
Nat Rev Microbiol. 2023 Mar;21(3):133-146. doi: 10.1038/s41579-022-00846-2. Epub 2023 Jan 13.
5
Comparison of COVID-19 and RSV Infection Courses in Infants and Children under 36 Months Hospitalized in Paediatric Department in Fall and Winter Season 2021/2022.2021/2022秋冬季节在儿科住院的36个月以下婴幼儿中新冠病毒肺炎与呼吸道合胞病毒感染病程的比较
J Clin Med. 2022 Nov 29;11(23):7088. doi: 10.3390/jcm11237088.
6
A systematic review and meta-analysis of the epidemiological characteristics of COVID-19 in children.一项关于儿童 COVID-19 流行病学特征的系统评价和荟萃分析。
BMC Pediatr. 2022 Oct 22;22(1):613. doi: 10.1186/s12887-022-03624-4.
7
The Omicron variant of concern: The genomics, diagnostics, and clinical characteristics in children.关注的奥密克戎变异株:儿童中的基因组学、诊断及临床特征
Front Pediatr. 2022 Aug 2;10:898463. doi: 10.3389/fped.2022.898463. eCollection 2022.
8
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis.2019 年全球、区域和国家因呼吸道合胞病毒导致 5 岁以下儿童急性下呼吸道感染的疾病负担估计:系统分析。
Lancet. 2022 May 28;399(10340):2047-2064. doi: 10.1016/S0140-6736(22)00478-0. Epub 2022 May 19.
9
Morbidity of Respiratory Syncytial Virus (RSV) Infections: RSV Compared With Severe Acute Respiratory Syndrome Coronavirus 2 Infections in Children Aged 0-4 Years in Cologne, Germany.呼吸道合胞病毒(RSV)感染的发病率:德国科隆 0-4 岁儿童中 RSV 与严重急性呼吸综合征冠状病毒 2 感染的比较。
J Infect Dis. 2022 Dec 13;226(12):2050-2053. doi: 10.1093/infdis/jiac052.
10
Airborne transmission of respiratory viruses.呼吸道病毒的空气传播。
Science. 2021 Aug 27;373(6558). doi: 10.1126/science.abd9149.